Unlike in our previous study on patients with primary biliary cholangitis (PBC)11 we detected no inhibition of CYP7A1 expression, which is a key mechanism involved in reducing hepatic BA synthesis. This evidence concerns the gene CYP7A1 and primary biliary cholangitis.